Abstract
Purpose
Attenuated Salmonella typhimurium is a potential biotherapeutic antitumor agent because it can colonize tumors and inhibit their growth. The present study aimed to develop a doxycycline (Doxy)-inducible gene switch system in attenuated S. typhimurium and assess its therapeutic efficacy in various tumor-bearing mice models.
Procedures
A Doxy-inducible gene switch system comprising two plasmids was engineered to trigger the expression of cargo genes (Rluc8 and clyA). Attenuated S. typhimurium carrying Rluc8 were injected intravenously into BALB/c mice bearing CT26 tumors, and bioluminescence images were captured at specified intervals post-administration of doxycycline. The tumor-suppressive effects of bacteria carrying clyA were evaluated in BALB/c mice bearing CT26 tumors and in C57BL/6 mice bearing MC38 tumors.
Results
Expression of the fimE gene, induced only in the presence of Doxy, triggered a unidirectional switch of the POXB20 promoter to induce expression of the cargo genes. The switch event was maintained over a long period of bacterial culture. After intravenous injection of transformed Salmonella into mice bearing CT26 tumors, the bacteria transformed with the Doxy-inducible gene switch system for Rluc8 targeted only tumor tissues and expressed the payloads 2 days after Doxy treatment. Notably, bacteria carrying the Doxy-inducible gene switch system for clyA effectively suppressed tumor growth and prolonged survival, even after just one Doxy induction.
Conclusions
These results suggest that attenuated S. typhimurium carrying this novel gene switch system elicited significant therapeutic effects through a single induction triggering and were a potential biotherapeutic agent for tumor therapy.
Similar content being viewed by others
References
Chau CH, Steeg PS, Figg WD (2019) Antibody–drug conjugates for cancer. Lancet 394:793–804
Zhong L, Li Y, Xiong L et al (2021) Small molecules in targeted cancer therapy: advances, challenges, and future perspectives. Signal Transduct Target Ther 6:201
Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R (2021) Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discovery 20:101–124
Sgouros G, Bodei L, McDevitt MR, Nedrow JR (2020) Radiopharmaceutical therapy in cancer: clinical advances and challenges. Nat Rev Drug Discovery 19:589–608
Loughlin KR (2020) William B. Coley: his hypothesis, his toxin, and the birth of immunotherapy. Urol Clin 47:413–417
Roberts NJ, Zhang L, Janku F et al (2014) Intratumoral injection of Clostridium novyi-NT spores induces antitumor responses. Sci Transl Med 6:249ra111
Longhi G, Van Sinderen D, Ventura M, Turroni F (2020) Microbiota and cancer: the emerging beneficial role of bifidobacteria in cancer immunotherapy. Front Microbiol 11:575072
Vitiello M, Evangelista M, Di Lascio N et al (2019) Antitumoral effects of attenuated Listeria monocytogenes in a genetically engineered mouse model of melanoma. Oncogene 38:3756–3762
Kang S-R, Jo EJ, Nguyen VH et al (2020) Imaging of tumor colonization by Escherichia coli using 18 F-FDS PET. Theranostics 10:4958
Nguyen VH, Kim H-S, Ha J-M, Hong Y, Choy HE, Min J-J (2010) Genetically engineered Salmonella typhimurium as an imageable therapeutic probe for cancer. Can Res 70:18–23
Lou X, Chen Z, He Z, Sun M, Sun J (2021) Bacteria-mediated synergistic cancer therapy: small microbiome has a big hope. Nano-Micro Lett 13:1–26
Zhou S, Gravekamp C, Bermudes D, Liu K (2018) Tumour-targeting bacteria engineered to fight cancer. Nat Rev Cancer 18:727–743
Sieow BF-L, Wun KS, Yong WP, Hwang IY, Chang MW (2021) Tweak to treat: reprograming bacteria for cancer treatment. Trends Cancer 7:447–464
Nguyen D-H, Chong A, Hong Y, Min J-J (2023) Bioengineering of bacteria for cancer immunotherapy. Nat Commun 14:3553
Kang S-R, Nguyen D-H, Yoo SW, Min J-J (2022) Bacteria and bacterial derivatives as delivery carriers for immunotherapy. Adv Drug Deliv Rev 181:114085
Chen W, Wang Y, Qin M et al (2018) Bacteria-driven hypoxia targeting for combined biotherapy and photothermal therapy. ACS Nano 12:5995–6005
Chien T, Harimoto T, Kepecs B et al (2022) Enhancing the tropism of bacteria via genetically programmed biosensors. Nat Biomed Eng 6:94–104
Dharanishanthi V, Orgad A, Rotem N et al (2021) Bacterial-induced pH shifts link individual cell physiology to macroscale collective behavior. Proc Natl Acad Sci 118:e2014346118
George SE, Hrubesch J, Breuing I et al (2019) Oxidative stress drives the selection of quorum sensing mutants in the Staphylococcus aureus population. Proc Natl Acad Sci 116:19145–19154
Qin Y, You S-H, Zhang Y, Venu A, Hong Y, Min J-J (2023) Genetic programming by nitric oxide-sensing gene switch system in tumor-targeting bacteria. Biosensors 13:266
Leventhal DS, Sokolovska A, Li N et al (2020) Immunotherapy with engineered bacteria by targeting the STING pathway for anti-tumor immunity. Nat Commun 11:2739
Nguyen D-H, You S-H, Vo A-TN et al (2022) Optimized doxycycline-inducible gene expression system for genetic programming of tumor-targeting bacteria. Mol Imag Biol 24:82–92
Zheng JH, Nguyen VH, Jiang S-N et al (2017) Two-step enhanced cancer immunotherapy with engineered Salmonella typhimurium secreting heterologous flagellin. Sci Transl Med 9:eaak9537
Cronin CA, Gluba W, Scrable H (2001) The lac operator-repressor system is functional in the mouse. Genes Dev 15:1506–1517
Jiang S-N, Park S-H, Lee HJ et al (2013) Engineering of bacteria for the visualization of targeted delivery of a cytolytic anticancer agent. Mol Ther 21:1985–1995
Wüst RC, Houtkooper RH, Auwerx J (2020) Confounding factors from inducible systems for spatiotemporal gene expression regulation. J Cell Biol 219 (7):e202003031
Cubillos-Ruiz A, Guo T, Sokolovska A et al (2021) Engineering living therapeutics with synthetic biology. Nat Rev Drug Discovery 20:941–960
Sedlmayer F, Aubel D, Fussenegger M (2018) Synthetic gene circuits for the detection, elimination and prevention of disease. Nat Biomed Eng 2:399–415
Ruder WC, Lu T, Collins JJ (2011) Synthetic biology moving into the clinic. Science 333:1248–1252
Lim WA (2010) Designing customized cell signalling circuits. Nat Rev Mol Cell Biol 11:393–403
Brophy JA, Voigt CA (2014) Principles of genetic circuit design. Nat Methods 11:508–520
Ham TS, Lee SK, Keasling JD, Arkin AP (2006) A tightly regulated inducible expression system utilizing the fim inversion recombination switch. Biotechnol Bioeng 94:1–4
Mohaisen MR, McCarthy AJ, Adriaenssens EM, Allison HE (2020) The site-specific recombination system of the Escherichia coli bacteriophage Φ24B. Front Microbiol 11:578056
Yao S, Yuan P, Ouellette B et al (2020) RecV recombinase system for in vivo targeted optogenomic modifications of single cells or cell populations. Nat Methods 17:422–429
Bonnet J, Subsoontorn P, Endy D (2012) Rewritable digital data storage in live cells via engineered control of recombination directionality. Proc Natl Acad Sci 109:8884–8889
Schwan WR (2011) Regulation of fim genes in uropathogenic Escherichia coli. World J Clin Infect Dis 1:17
Klemm P (1986) Two regulatory fim genes, fimB and fimE, control the phase variation of type 1 fimbriae in Escherichia coli. EMBO J 5:1389–1393
McCusker MP, Turner EC, Dorman CJ (2008) DNA sequence heterogeneity in Fim tyrosine-integrase recombinase-binding elements and functional motif asymmetries determine the directionality of the fim genetic switch in Escherichia coli K-12. Mol Microbiol 67:171–187
Lawrence A-LE, Abuaita BH, Berger RP et al (2021) Salmonella enterica serovar Typhimurium SPI-1 and SPI-2 shape the global transcriptional landscape in a human intestinal organoid model system. MBio 12:e00399-e321
Liss V, Swart AL, Kehl A et al (2017) Salmonella enterica remodels the host cell endosomal system for efficient intravacuolar nutrition. Cell Host Microbe 21:390–402
Jennings E, Thurston TL, Holden DW (2017) Salmonella SPI-2 type III secretion system effectors: molecular mechanisms and physiological consequences. Cell Host Microbe 22:217–231
Yang L, Nielsen AA, Fernandez-Rodriguez J et al (2014) Permanent genetic memory with> 1-byte capacity. Nat Methods 11:1261–1266
National Research Council (2011) Guide for the care and use of laboratory animals: eight edition. National Academies Press, Washington, DC. Available from: https://www.ncbi.nlm.nih.gov/books/NBK54050/, https://doi.org/10.17226/12910
Chowdhury S, Castro S, Coker C, Hinchliffe TE, Arpaia N, Danino T (2019) Programmable bacteria induce durable tumor regression and systemic antitumor immunity. Nat Med 25:1057–1063
Harbaugh SV, Goodson MS, Dillon K, Zabarnick S, Kelley-Loughnane N (2017) Riboswitch-based reversible dual color sensor. ACS Synth Biol 6:766–781
Sun B, Zhang S, Zhang D, Yin X, Wang S, Gu Y, Wang Y (2007) Doxycycline influences microcirculation patterns in B16 melanoma. Exp Biol Med 232:1300–1307
Kosobokova E, Skrypnik K, Kosorukov V (2016) Overview of fusion tags for recombinant proteins. Biochem Mosc 81:187–200
Hajnsdorf E, Kaberdin VR (2018) RNA polyadenylation and its consequences in prokaryotes. Philos Trans R Soc B: Biol Sci 373:20180166
Frederick MI, Heinemann IU (2021) Regulation of RNA stability at the 3′ end. Biol Chem 402:425–431
Ki M-R, Pack SP (2020) Fusion tags to enhance heterologous protein expression. Appl Microbiol Biotechnol 104:2411–2425
Funding
This work was supported by the Bio & Medical Technology Development Program of National Research Foundation of Korea (NRF) (No. NRF-2020M3A9G3080282), NRF grants (Nos. 2020R1A5A2031185, 2021M3C1C3097637, 2021C300) funded by Ministry of Science and IT (MSIT), and by the Korea Drug Development Fund funded by Ministry of Science and ICT, Ministry of Trade, Industry, and Energy, and Ministry of Health and Welfare (HN22C0637, RS-2022-00167101). Y.H. was supported by the Bio & Medical Technology Development Program of NRF (No. NRF-2020M3A9G3080330).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of Interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Ngo, H.TT., Nguyen, DH., You, SH. et al. Reprogramming a Doxycycline-Inducible Gene Switch System for Bacteria-Mediated Cancer Therapy. Mol Imaging Biol 26, 148–161 (2024). https://doi.org/10.1007/s11307-023-01879-6
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1007/s11307-023-01879-6